- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05894655
Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex)
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents, the ethnic minority community most impacted by COVID-19 in San Diego. In the Phase I project, University of California, San Diego (UCSD) partnered with San Ysidro Health (SYH) and the Global Action Research Center, to co-create and demonstrate the impact of a COVID-19 testing program in San Ysidro, one of the most impacted areas from COVID-19 in San Diego County. To date, the project tested >10,000 community members (92% Latino) and received requests to scale-out the testing program to additional primary care clinic sites.
In this Phase III project, Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex) will extend work with the Phase I community and clinical partners to refine, specify, implement, and evaluate an implementation strategy bundle that optimizes COVID-19 testing, expanding beyond current polymerase chain reaction (PCR) testing to FDA-authorized COVID-19 rapid antigen testing.
Study Overview
Status
Conditions
Detailed Description
CO-CREATE-Ex will roll-out our implementation using 3 strategies:
- keeping the current, walk-up free testing protocol
- Offering Community Health Worker (CHW) to lead COVID-19 test counseling, preventive care reminders, and offer testing support
- Installing vending machines that will dispense FDA-authorized self-testing kits.
For each strategy, participants will consent into study, provide demographics and test history, and receive a free rapid antigen test (RAT) kit. After receiving the test kit, participants will be prompted to return their results and fill out a survey about their COVID-19 experiences. Study subjects will be contacted up to three times over a course of 4 weeks to return their results and complete the survey. Study coordinators will use participants' preferred method of contact.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Ysidro, California, United States, 92173
- San Ysidro Health Centers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Speak English and/or Spanish
- Affiliated with San Ysidro Health as a patient at select clinics (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights) OR
- A member of a community near a San Ysidro Health clinic (San Ysidro, Chula Vista, Lincoln Park, and Logan Heights).
Exclusion Criteria:
- Institutionalization for psychiatric disorder, developmental delay, or criminal activity.
- Unable to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: San Ysidro Health Center - Main Clinic
At the main clinic all 3 strategies will be available: walk-up testing, vending machine, and Community Health Worker (CHW) providing education.
|
This strategy is a no-appointment, walk-up point-of-care PCR and rapid testing strategy for clinic patients and community members.
It will be offered 5 days/week for 7 hours during the first 3 months of the trial at Clinic 1.
The intensity will decrease over the trial ending with 1 SYH Medical Assistant overseeing the testing protocol.
Bilingual research staff will be trained to oversee onsite testing.
This strategy provides health counseling about when COVID-19 testing is recommended, which test to use, testing instructions, and how to interpret results.
Community Health Workers (CHW) will also offer general preventive health care reminders such as flu shots, blood pressure checks, and A1c screenings.
This strategy will be available full-time during the first 3 months of roll-out at each clinic and after 3 months, the CHW will be available as needed.
Trained bilingual CHW will be supervised by a SYH employee.
This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime.
The vending machines will be available 24 hours/day, 7 days a week.
|
|
Experimental: San Ysidro Health Center - Logan Heights
A vending machine and Community Health Worker (CHW) providing education will be available at Logan Heights
|
This strategy provides health counseling about when COVID-19 testing is recommended, which test to use, testing instructions, and how to interpret results.
Community Health Workers (CHW) will also offer general preventive health care reminders such as flu shots, blood pressure checks, and A1c screenings.
This strategy will be available full-time during the first 3 months of roll-out at each clinic and after 3 months, the CHW will be available as needed.
Trained bilingual CHW will be supervised by a SYH employee.
This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime.
The vending machines will be available 24 hours/day, 7 days a week.
|
|
Experimental: San Ysidro Health Center - Lincoln Park
A vending machine and Community Health Worker (CHW) providing education will be available at Lincoln Park
|
This strategy provides health counseling about when COVID-19 testing is recommended, which test to use, testing instructions, and how to interpret results.
Community Health Workers (CHW) will also offer general preventive health care reminders such as flu shots, blood pressure checks, and A1c screenings.
This strategy will be available full-time during the first 3 months of roll-out at each clinic and after 3 months, the CHW will be available as needed.
Trained bilingual CHW will be supervised by a SYH employee.
This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime.
The vending machines will be available 24 hours/day, 7 days a week.
|
|
Experimental: San Ysidro Health Center - Chula Vista
A vending machine and Community Health Worker (CHW) providing education will be available at Chula Vista
|
This strategy provides health counseling about when COVID-19 testing is recommended, which test to use, testing instructions, and how to interpret results.
Community Health Workers (CHW) will also offer general preventive health care reminders such as flu shots, blood pressure checks, and A1c screenings.
This strategy will be available full-time during the first 3 months of roll-out at each clinic and after 3 months, the CHW will be available as needed.
Trained bilingual CHW will be supervised by a SYH employee.
This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime.
The vending machines will be available 24 hours/day, 7 days a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify solutions and evaluation methods to refine a multi-component implementation strategy bundle using a Community and Scientific Advisory Board.
Time Frame: 2 years
|
The primary objective is to refine and operationalize the multi-component implementation strategy bundle and measures of implementation and sustainment success for rapid FDA-authorized COVID-19 rapid testing using the partnership with the Global Arc and Community and Scientific Advisory Board.
Each session will be recorded while Global Arc partners guide the board to identify potential failures in the implementation design.
Measures of success will be collected by partner engagement surveys, which will be administered and analyzed after each meeting.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of distributed rapid antigen tests within our target communities as measured by a proxy outcome.
Time Frame: 18 months
|
The secondary objective is to implement and evaluate the impact of our multicomponent implementation strategy bundle to optimize COVID-19 rapid testing among underserved, Latino communities.
Implementation strategies include a vending machine, Community Health Workers, and walk-up testing tables.
Each strategy will be rolled-out across four clinics over 18 months.
|
18 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Louise Laurent, MD/PhD, University of California, San Diego
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Respiratory Tract Infections
- Infections
- RNA Virus Infections
- Virus Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Pneumonia, Viral
- Pneumonia
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- Behavior
- Treatment Adherence and Compliance
- Health Behavior
- Treatment Refusal
- Vaccination Refusal
- COVID-19
- Vaccination Hesitancy
- Health Care Facilities Workforce and Services
- Health Personnel
- Allied Health Personnel
- Community Health Workers
Other Study ID Numbers
- 806121
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
Clinical Trials on COVID-19 walk-up, on-site testing strategy
-
Mayo ClinicCompletedCoronavirus Disease (COVID-19)United States